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ABSTRACT 
The nucleotide signaling molecule 3’,5’-cyclic 
adenosine monophosphate (3’,5’-cAMP) plays 
important physiological roles, ranging from carbon 
catabolite repression in bacteria to mediating the 
action of hormones in higher eukaryotes, including 
human. However, it remains unclear whether 
3’,5’-cAMP is universally present in the 
Firmicutes group of bacteria. We hypothesized that 
searching for proteins that bind 3’,5’-cAMP might 
provide new insight into this question. 
Accordingly, we performed a genome-wide screen, 
and identified the essential Staphylococcus aureus 
tRNA m1G37 methyltransferase enzyme TrmD, 
which is conserved in all three domains of life, as 
a tight 3’,5’-cAMP binding protein. TrmD 
enzymes are known to use S-adenosyl-L-
methionine (AdoMet) as substrate; we shown that 
3’,5’-cAMP binds competitively with AdoMet to 
the S. aureus TrmD protein, indicating an 
overlapping binding site. However, the 
physiological relevance of this discovery remained 
unclear, as we were unable to identify a functional 
adenylate cyclase in S. aureus and only detected 
2’,3’-cAMP but not 3’,5’-cAMP in cellular 
extracts. Interestingly, TrmD proteins from 
Escherichia coli and Mycobacterium tuberculosis, 
organisms known to synthesize 3’,5’-cAMP, did 
not bind this signaling nucleotide. Comparative 
bioinformatics, mutagenesis and biochemical 
analyses revealed that the highly conserved Tyr86 
residue in E. coli TrmD is essential to discriminate 
between 3’,5’-cAMP and the native substrate 
AdoMet. Combined with a phylogenetic analysis, 
these results suggest that amino acids in the 
substrate binding pocket of TrmD underwent an 
adaptive evolution to accommodate the emergence 
of adenylate cyclases and thus the signaling 
molecule 3’,5’-cAMP. Altogether this further 
indicates that S. aureus does not produce 3’,5’-
cAMP, which would otherwise competitively 
inhibit an essential enzyme. 
3’,5’-cyclic adenosine monophosphate 
(3’,5’-cAMP) is a second messenger molecule 
found in all three domains of life (1). It is involved 
in the regulation of a variety of physiological 
processes ranging from carbon catabolite 
repression (CCR) in bacteria to mediating the 
action of hormones in eukaryotes (1). CCR exists 
in most bacteria and describes the phenomenon 
that certain carbon sources (usually glucose) are 
preferentially catabolized over other secondary 
carbon sources. This is achieved through complex 
positive and negative regulatory transcription 
networks (2). CCR is well studied in Escherichia 
coli, where 3’,5’-cAMP and the catabolite receptor 
protein CRP form together an active 
transcriptional factor that activates the expression 
of genes coding for proteins involved in 
catabolizing secondary carbon sources when 
glucose is exhausted (2). 3’,5’-cAMP is 
synthesized from ATP by adenylate cyclases 
(ACs), a large family of enzymes with divergent 
sequence, domain and structural features (1). So 
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far, six classes of ACs have been reported, with 
class III enzymes found in all domains of life and 
class I, II, IV only present in bacteria (1). The ACs 
identified in Prevotella ruminicola and Rhizobium 
etli, are distinct from the existing families and 
were proposed to form Class V and VI enzymes, 
respectively (3,4). Class I ACs are exemplified by 
the E. coli CyaA enzyme; class II ACs are 
bacterial toxins most often secreted into eukaryotic 
host cells where they perturb host cell functions 
(5). Lastly, class IV ACs are a unique group of 
proteins only found in bacteria, but forming part of 
larger protein family called CYTH domain 
proteins (6,7). CYTH proteins are an ancient 
protein family that exist in all three domains of life 
and are named after the type IV AC CyaB from 
Aeromonas hydrophila and the human thiamine 
triphosphatase (ThTPase). It has been proposed 
that these enzymes were originally inorganic 
tripolyphosphatases and subsequently evolved to 
contain other enzymatic activities such as 
adenylate cyclase, mRNA triphosphatase and 
ThTPase activity (6,7). CYTH proteins contain a 
characteristic and highly conserved ExExK amino 
acid motif at their N-terminus and have a 
conserved fold with eight β-sheets forming a 
tunnel-like structure (6). Various other conserved 
charged amino acids with their side chains 
projecting into the tunnel have been identified and 
these are involved in coordinating the different 
polyphosphate substrates or are involved in 
enzyme catalysis (6,8-10). 
While ACs enzymes are in general widely 
distributed among bacteria, there is conflicting 
evidence if 3’,5’-cAMP is produced and plays a 
physiological role in the Firmicutes group of 
bacteria. While a bioinformatics analysis 
performed by Galperin and collaborators on 555 
complete bacterial and archaeal proteomes 
indicated that adenylate cyclase enzymes are 
absent in the majority of Firmicutes bacteria, 
including S. aureus (11), a protein corresponding 
to SACOL1008 of S. aureus strain COL is 
nevertheless often annotated as adenylate cyclase. 
However, the predicted cyclase activity of this 
protein has never been tested. It has also been 
reported that 3’,5’-cAMP is present in Bacillus 
subtilis when grown under oxygen limitation 
conditions and its level were shown to decrease in 
the presence of nitrate (12,13). However, in these 
studies, the molecule suggested to be 3’,5’-cAMP 
was identified only through chromatographic 
methods and its actual chemical structure was 
never confirmed by other methods, such as mass 
spectrometry which is now routinely used. In S. 
aureus, ArcR (SACOL2653 in strain COL), a 
member of the CRP/FNR family of bacterial 
transcriptional regulators, plays a role in mediating 
catabolite repression by inducing the arginine 
deiminase operon genes arcABDC under anaerobic 
conditions (14). Furthermore, 3’,5’-cAMP was 
shown in in vitro assays to enhance the ability of 
ArcR to bind to the promoter region of the lctE 
gene, encoding an L-lactate dehydrogenase (14). 
However, if 3’,5’-cAMP is actually present in S. 
aureus and has a similar effect on ArcR in vivo 
was never tested. 
In this study we wanted to shed further 
light on whether or not 3’,5’-cAMP is produced 
and plays a physiological function in S. aureus. 
Using an S. aureus ORFeome protein expression 
library, we screened for 3’,5’-cAMP binding 
proteins and identified TrmD as a tight 3’,5’-
cAMP binding protein. However, we were unable 
to detect 3’,5’-cAMP under various growth 
conditions nor a functional adenylate cyclase in S. 
aureus. TrmD is a highly conserved tRNA 
methyltransferase and present in all three domains 
of life (15). It converts G37 into m1G37 by 
transferring the methyl group from S-
adenosylmethionine (AdoMet) to a subset of tRNA 
species (15,16). We further found that TrmD 
proteins from E. coli and Mycobacterium 
tuberculosis do not bind 3’,5’-cAMP. Subsequent 
bioinformatics and extensive biochemical analyses 
suggested that 3’,5’-cAMP competes with AdoMet 
for binding, presumably inhibiting the essential 
function of TrmD in S. aureus. Together with a 
phylogeny analysis, our data suggest that 3’,5’-
cAMP is absent in Staphylococcus. Finally, our 
work also highlights that the emergence of 3’,5’-
cAMP as signaling molecule in bacteria required 
essential evolutionary adaptations of AdoMet-
binding proteins such as TrmD. 
 
RESULTS 
Identification of the S. aureus TrmD protein as 
a 3’,5’-cAMP binding protein. There is 
 	 3 
conflicting evidence whether or not 3’,5’-cAMP 
exists in the Firmicutes group of bacteria. We 
reasoned that, if 3’,5’-cAMP is indeed present and 
functionally relevant in S. aureus, specific 3’,5’-
cAMP-binding protein(s) must exist. To 
investigate this, we made use of an S. aureus 
ORFeome protein expression library and the 
differential radial capillary action of ligand assay 
(DRaCALA), a simple and fast method for the 
detection of small molecule-protein interactions 
(17-19). The DRaCALA method is based on the 
principle that free radiolabeled small ligand will 
diffuse outward once spotted on a nitrocellulose 
membrane, but will stay as a tight spot when 
bound to a protein (17). In previous studies, this 
assay and the ORFeome protein expression library 
was successfully used to identify c-di-AMP and 
ppGpp binding proteins in S. aureus (18-20). The 
ORFeome protein expression library is a collection 
of 2337 E. coli strains allowing for the 
overproduction of 86% of the annotated S. aureus 
strain COL proteins as His-MBP-fusion proteins 
(18-20). To apply this assay to the identification of 
potential 3’,5’-cAMP binding proteins, the 
expression of the S. aureus proteins was induced 
and E. coli cell lysates prepared. Next, 
radiolabeled 32P-cAMP was synthesized using a C-
terminal truncated form of the E. coli adenylate 
cyclase enzyme CyaA. As assessed by TLC, 97% 
of the input [α-32P]-ATP was converted to [α-32P]-
cAMP (data not shown). The genome wide 
DRaCALA screen was subsequently performed as 
previously described (18-20). Two technical 
replicates were performed and the lysate from one 
strain expressing the S. aureus COL protein 
SACOL1256 (plate 13 well F05) gave a positive 
result for 3’,5’-cAMP binding (data not shown). 
SACOL1256 (or SAUSA300_1133 in the USA300 
strain FPR3757) codes for the tRNA 
methyltransferase TrmD, termed from here on out 
as TrmDSA. To further investigate if TrmDSA can 
bind 3’,5’-cAMP with a physiological relevant 
affinity, SAUSA300_1133 from the USA300 
strain LAC* was cloned into vector pET28b and 
the protein expressed and purified as N-terminally 
His-tagged fusion protein. DRaCALAs were 
carried out with 32P-cAMP and serially diluted 
TrmDSA protein ranging from 200 µM to 1.5 nM 
and a Kd of 1.97 ± 0.24 µM was determined (Fig. 
1A). This binding affinity is in a similar range as 
the reported Kd of 2 µM for the interaction 
between the E. coli transcription factor CRP and 
3’,5’-cAMP (21). To test if the binding is specific 
to 3’,5’-cAMP, an excess of the cold competitor 
nucleotides 3’,5’-cAMP, 3’,5’-cGMP, c-di-GMP, 
c-di-AMP were added to the binding reaction. This 
analysis revealed that only cold 3’,5’-cAMP but 
none of the other nucleotides tested could compete 
for binding with the radiolabeled 32P-cAMP (Fig. 
1B). Two forms of cAMP have been detected in 
cells, 3’,5’-cAMP, the classic signaling nucleotide, 
and 2’,3’-cAMP, suggested to be a nucleotide 
intermediate formed during the RNA degradation 
process (22,23). As revealed by competitive 
binding assays, only the classic signaling molecule 
3’,5’-cAMP but not 2’,3’-cAMP could prevent the 
binding of radiolabeled 3’,5’-cAMP to TrmDSA 
(Fig. 1B). Taken together, these data show that the 
S. aureus TrmD protein is able to bind the 3’,5’-
cAMP signaling nucleotide with high affinity. 
However, it is also of note that no interaction 
between 3’,5’-cAMP and the S. aureus ArcR 
protein, a transcription factor with homology to 
the E. coli CRP protein could be detected (Fig. 
1C). 
3’,5’-cAMP competitively binds at the AdoMet 
substrate-binding site of the S. aureus TrmD 
protein. TrmD is a highly conserved and essential 
enzyme and present in nearly all bacteria. TrmD is 
responsible for methylating the G37 residue at the 
N1 position in a subset of tRNAs using S-
adenosylmethionine (AdoMet) as methyl-donor 
(15). Since 3’,5’-cAMP is chemically similar to 
AdoMet and both contain an adenine moiety and a 
ribose ring (Fig. 1D), this raised the possibility 
that 3’,5’-cAMP binds at the AdoMet substrate 
binding site of TrmDSA. Indeed, as revealed by a 
competitive binding assay, AdoMet could inhibit 
in a dose dependent manner the binding of 
radiolabeled 3’,5’-cAMP to TrmDSA (Fig. 1B). 
Next, isothermal titration calorimetry (ITC) 
experiments were performed and a Kd of 121.4 
µM was determined for AdoMet binding to 
TrmDSA. Of note, the TrmDSA and AdoMet 
interaction was determined by ITC and not 
DRaCALA, as the latter method can only be used 
for high affinity binding interactions (low µM Kd 
or below) and using a radiolabeled ligand. Taken 
together, these data indicate that 3’,5’-cAMP binds 
at the same site as the natural substrate AdoMet 
consistent with a competitive binding mechanism.  
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2’,3’-cAMP, but not 3’,5’-cAMP, can be 
detected in S. aureus extracts. Previous work 
indicated that cAMP is produced in B. subtilis 
when grown without aeration under oxygen 
limitation conditions (12,13). However, it should 
be noted that cAMP production was only assessed 
using chromatographic methods and its chemical 
structure was never confirmed by NMR or mass-
spectrometry based-method (12,13). Given the fact 
that we uncovered a 3’,5’-cAMP binding protein 
in S. aureus, we next set out to determine if and 
when 3’,5’-cAMP is produced in S. aureus using a 
sensitive mass spectrometry-based method (24). 
Cytosolic extracts were prepared from the wild-
type S. aureus strain JE2 and strain NE1299, 
containing a transposon insertion in 
SAUSA300_0905, coding for an uncharacterized 
protein often annotated as adenylate cyclase. The 
strains were grown in TSB medium under aerobic 
or micro-aerobic conditions as well as in B-
medium supplemented with either glucose or 
sucrose as the only carbon source to reflect carbon 
catabolite repression in S. aureus (25). Extracts 
were prepared from both exponential and 
stationary phase cultures and nucleotides detected 
by LC-MS/MS as described in Bähre et al (24). 
Using this sensitive method, 3’,5’-cAMP 
concentrations can be detected up to a lower limit 
of 0.412 pmol per sample and also discriminated 
from 2’,3’-cAMP. Large amounts of 2’,3’-cAMP 
were detected in all samples (Fig. 2). 
Normalization based on total protein 
concentrations, revealed higher 2’,3’-cAMP levels 
in extracts prepared from strains grown in TSB 
medium under micro-aerobic than under aerobic 
conditions (Fig. 2). The 2’,3’-cAMP levels were 
even higher when bacteria were grown in B-
medium (Fig. 2). Of note, more 2’,3’-cAMP was 
also present in extracts prepared from stationary 
than exponential phase cells, when the bacteria 
were grown in B-medium supplemented with 
glucose. While high levels of 2’,3’-cAMP could be 
detected in all samples, 3’,5’-cAMP was not 
detected in any of the extracts suggesting that S. 
aureus does not produce 3’,5’-cAMP at least 
under the conditions tested.  
SAUSA300_0905 and its homologs are distinct 
from type IV AC enzymes. An initial 
bioinformatics analysis indicated that the predicted 
S. aureus adenylate cyclase SAUSA300_0905 
(USA300 FPR3757 nomenclature) is most closely 
related to type IV AC enzymes. It is possible that 
the SAUSA300_0905 protein was not expressed or 
active under the growth conditions tested and 
hence we were unable to detect 3’,5’-cAMP in the 
S. aureus extracts. To test if SAUSA300_0905 is 
able to synthesize 3’,5’-cAMP in vitro, the protein 
was expressed and purified from E. coli as N-
terminal His-tag fusion protein. The E. coli CyaA2-
446 protein was purified and used as positive 
control. Radiolabeled [α-32P]-ATP was used as 
substrate and reactions were set up in three 
different buffers, as previously reported for in vitro 
enzyme assays with the E. coli CyaA (26) or the Y. 
pestis type IV AC CyaB (8). The enzyme reactions 
were incubated for 1 h or overnight at 37oC and 
the reaction products subsequently analyzed by 
TLC. Within 1 h, the E. coli CyaA2-446 enzyme 
converted more than 91% and 61% of the ATP to 
cAMP in the Mg2+ and Mn2+ containing buffers, 
respectively; however, none of the [α-32P]-ATP 
was converted by SAUSA300_0905 (Fig. 3A). 
Overnight reactions essentially yielded similar 
results (data not shown). 
Genes coding for active AC enzymes have 
previously been identified through their ability to 
complement an E. coli cyaA mutant strain using 
simple plate assays, as 3’,5’-cAMP-producing E. 
coli strains appear red or blue on MacConkey or 
X-Gal containing plates, respectively (3,4,27). To 
test if SAUSA300_0905 is able to produce 3’,5’-
cAMP when expressed in E. coli, 
SAUSA300_0905 and as a positive control the E. 
coli cyaA2-446 gene were cloned with an N-terminal 
His-tag in vector pBAD33 and expressed under 
the control of the arabinose inducible promoter. 
The resulting plasmids, pBAD33-
SAUSA300_0905-His6 and pBAD33-cyaA2-446-
His6, and the empty vector pBAD33 as negative 
control, were introduced into the cyaA mutant E. 
coli strain DHM1 and plated on LB agar plates 
supplemented with 10 µg/ml chloramphenicol, 
0.02% w/v arabinose and 50 µg/ml X-Gal. 
Introduction of plasmid pBAD33-CyaA2-446-His6 
in strain DHM1 yielded solid blue colonies, while 
the empty vector and pBAD33-SAUSA300_0905 
containing cells gave white colonies (Fig. 3B). 
Western blot analysis confirmed that both proteins, 
CyaA2-446--His6 and SAUSA300_0905-His6, were 
expressed (Fig. 3C). These data indicate that 
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SAUSA300_0905 may not be an active adenylate 
cyclase. 
To investigate this further, we re-visited the 
annotation of SAUSA300_0905 by performing a 
detailed bioinformatics analysis. 
SAUSA300_0905 was used in a BLASTP search, 
the result of which indicated that it belongs to the 
CYTH superfamily of protein similar to bona fide 
type IV adenylate cyclases. Next, homologs of 
SAUSA300_0905 were retrieved from the NCBI 
non-redundant (nr) protein sequence database and 
this yielded 998 sequences with a minimum of 
30% sequence identity and 60% sequence 
coverage. To compare SAUSA300_0905 with a 
genuine type IV adenylate cyclases, CyaB from Y. 
pestis was used as query sequence to retrieve its 
closest homologs from the NCBI nr database. This 
yielded 562 sequences with a minimum of 30% 
sequence identity and 60% sequence coverage. 
But none of the CyaB homologs were from the 
Firmicutes group of bacteria. Next, multiple 
sequence alignments were performed within each 
group of proteins and sequence logos generated 
(Fig. 4A). A multiple sequence alignment was also 
performed across the two groups of proteins. This 
analysis revealed that the ExExK signature motif 
of CYTH family protein (denoted by grey stars in 
Fig. 4A) is conserved in both groups of proteins. 
However, key residues required for the adenylate 
cyclase activity of type IV ACs such as K111, 
R113, which are essential for forming hydrogen 
bonds with the α- and β- phosphate groups of ATP 
or F5, C83, R113, E136 (green stars in Fig. 4A) 
that have been shown to be required for adenylate 
cyclase activity (8) are absent in SAUSA300_0905 
and its homologs. On the other hand, a unique and 
highly conserved DxExExE motif (yellow stars in 
Fig. 4A) was identified within the C-terminal 
region of SAUSA300_0905 and its homologs, 
which is absent from type IV ACs. Phyre2 was 
then used to generate a structure model of 
SAUSA300_0905 (using bh2851, a putative 
adenylate cyclase from Bacillus halodurans, with 
PDB code 2GFG as template, 94% of residues 
modelled at >90% confidence). This analysis 
suggested that the S. aureus protein 
SAUSA300_0905 does assume a fold typical for 
CYTH proteins with a tunnel-like structure similar 
to CyaB (PDB code 3N0Y) (Fig. 4B). Despite the 
similar structural fold, the absence of key residues 
required for adenylate cyclase activity and the 
presence of other conserved residues at the C-
terminus of the SAUSA300_0905 indicates that 
this protein is distinct from type IV adenylate 
cyclases and therefore may have a different 
enzymatic activity. Lastly, using the E. coli CyaA, 
B. anthracis CyaA P40136, Arthrospira platensis 
CyaC O32393, Prevotella ruminicola Cya 
O68902, Rhizobium etli CyaC Q8KY20 proteins 
as representatives of type I, II, III, V, VI ACs, 
respectively, in BLASTP searches no proteins with 
significant similarity were found in 
Staphylococcaceae. These data suggest that no AC 
enzyme for the production of the classic signaling 
nucleotide 3’,5’-cAMP is encoded in S. aureus. 
TrmDs from E. coli and Mycobacterium 
tuberculosis do not bind 3’,5’-cAMP. Our results 
so far indicate that 3’,5’-cAMP can in in vitro 
assays competitively bind to the AdoMet substrate 
binding site of the S. arueus TrmD protein. On the 
other hand, we were unable to detect 3’,5’-cAMP 
in S. aureus extracts nor an enzyme that would be 
able to produce this signaling nucleotide. Hence, 
the interaction of 3’,5’-cAMP and the S. aureus 
TrmD protein may not be of physiological 
relevance. However, TrmD is a highly conserved 
protein and present in a large number of bacteria 
that have been experimentally shown to produce 
3’,5’-cAMP. This raises the possibilities that in 
these organisms 3’,5’-cAMP could either be a 
competitive inhibitor of TrmD enzyme or 
alternatively that TrmD proteins evolved to 
discriminate between the 3’,5’-cAMP and AdoMet 
ligands. To address this question, TrmD proteins 
from the 3’,5’-cAMP producing γ-proteobacterium 
E. coli (TrmDEC) and the actinobacterium M. 
tuberculosis (TrmDMT) were chosen for further 
analysis. The genes coding for the corresponding 
TrmD proteins were cloned in the pET28b vector, 
the proteins expressed and purified as N-terminal 
His-tagged proteins (Fig. 5A). DRaCALAs were 
performed with radiolabeled 3’,5’-cAMP and the 
purified TrmDEC and TrmDMT proteins. This 
analysis revealed that neither protein could bind 
3’,5’-cAMP as tightly as the S. aureus TrmDSA 
protein and due to this weak interaction no actual 
Kd value could be determined using the 
DRaCALA method (Fig. 5B). These data suggest 
that TrmD proteins from organisms producing 
3’,5’-cAMP are able to discriminate between 
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3’,5’-cAMP and the AdoMet ligand, likely 
preventing 3’,5’-cAMP to act as competitive 
inhibitor and blocking the essential functions of 
TrmD. 
Tyr86 is critical for discriminating 3’,5’-cAMP 
from AdoMet in E. coli TrmD. The difference in 
the capacity of the S. aureus, E. coli and M. 
tuberculosis TrmD proteins to bind 3’,5’-cAMP, 
indicates critical difference in their primary 
sequences and tertiary structures. To gain further 
insight into this, each of the TrmD proteins was 
used to retrieve their close homologs from their 
respective groups (that is Firmicutes, γ-
Proteobacteria and Actinobacteria). Multiple 
sequence alignments were performed individually 
within each group and sequence logos generated 
using Jalview (Fig. 6A) (28). This analysis 
revealed three highly conserved motifs termed 
here A, B, and C, which based on previous 
structural and functional analysis are known to 
form the active site and the AdoMet substrate 
binding pocket in TrmD proteins (Fig. 6B) 
(29,30). Among these motifs, the motifs B and C 
with consensus sequences 
CG(H/R)YEGxD(E/Q)R and 
ExSxGD(Y/F)VLxGGE, respectively, are 
essentially the same in all three groups of bacteria 
(Fig. 6A). However, motif A differs significantly, 
with the consensus sequence YLSPQG in 
Proteobacteria, VPTPAG in Actinobacteria and the 
degenerated consensus sequence 
(L/Y)(L/M)xP(Q/A)G in Firmicutes (Fig. 6A). In 
particular, the first three amino acids of motif A, 
referred to from here on out as motif A1, show 
very low conservation in the Firmicutes group of 
bacteria. To visualize the location of these motifs 
in a structural context, a multiple sequence 
alignment was created for the TrmD proteins from 
all three groups. The alignment was subsequently 
mapped on the crystal structure of the TrmD 
protein from Hemophilus influenza (PDB code 
1UAK), a member of the γ-proteobacteria group 
and displayed in the Consurf view (31). As 
expected, the three motifs, including the A1 motif, 
form the binding pocket for AdoMet on TrmD. 
The A1 motif area appears as white patch in the 
Consurf view, indicative of a lower conservation 
(Fig. 6B). To gain a better understanding of the 
location of the amino acids within the A1 motif in 
the context of the protein/AdoMet ligand 
interactions, a comparative structural alignment 
was performed with PYMOL using the available 
crystal structures of the S. aureus TrmD protein 
(PDB code 3KY7) and the H. influenza TrmD 
protein (PDB code 1UAK), the latter of which has 
been crystalized in the presence of AdoMet. As 
shown in the H. influenza TrmD/AdoMet complex 
structure, the Tyr residue at the beginning of the 
A1 motif (corresponding to Tyr86 in E. coli 
TrmDEC) and highly conserved in Proteobacteria, 
forms hydrogen bonds with the 3’-OH and 2’-OH 
of the ribose ring in AdoMet (Fig. 7A). The 
corresponding 3’-OH group in 3’,5’-cAMP forms 
a phosphoester bond with the 5’-phosphate group 
(Fig. 7A), and hence would not be available for 
such a hydrogen bond interaction. This 
observation indicates that Tyr86 in TrmDEC might 
play a critical role in discriminating AdoMet from 
3’,5’-cAMP by forming an additional hydrogen 
bond with AdoMet. Consistent with this idea, a 
Leu residue is present at the corresponding 
position in the A1 motif of the S. aureus TrmDSA 
protein, which could not form a hydrogen bond 
with the 3’-OH of AdoMet, and this may allow 
TrmDSA to bind AdoMet as well as 3’,5’-cAMP. 
To test this hypothesis, the LMC amino acid 
residues of the TrmDSA A1 motif were replaced 
with YLS residues as found in TrmDEC. This 
variant was expressed and purified as N-terminal 
His-tagged protein (Fig. 5A). As assessed by 
DRaCALAs, this variant showed a decreased 
binding affinity for 3’,5’-cAMP (Fig. 7B). 
Conversely, the Tyr86 residue in the TrmDEC 
protein was replaced with a Phe (lacking the 
phenol hydroxyl group of Tyr) or Leu residue as 
present in TrmDSA, yielding the TrmDECY86F and 
TrmDECY86L variants, respectively (Fig. 5A). The 
TrmDECY86F variant was still unable to bind 
3’,5’-cAMP (similar to WT TrmDEC); however, 
the TrmDECY86L variant had a much increased 
binding affinity for 3’,5’-cAMP (Fig. 7C). These 
findings were corroborated further by ITC 
experiments. Due to the weak binding no Kd 
values could be determined for the interaction 
between 3’,5’-cAMP and the WT TrmDEC protein 
and the TrmDECY86F variant; however the 
TrmDECY86L variant was able to bind 3’,5’-cAMP 
with a Kd of 41.2 µM. On the other hand, this 
variant had now a decreased binding affinity for 
AdoMet with a Kd of 69.9 µM; while the WT 
TrmDEC and the TrmDECY86F variants had similar 
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and high binding affinities for AdoMet with Kd 
values of 21.5 µM and 27.9 µM, respectively. 
Taken together, these data indicate that the highly 
conserved Tyr86 residue in E. coli TrmD, and 
likely also in other γ-proteobacteria, is important 
for discriminating between 3’,5’-cAMP and 
AdoMet, preventing the binding of the former, 
which otherwise could competitively inhibit the 
enzyme.  
Coevolution of TrmD with the emergence of the 
3’5’-cAMP signaling pathway. The fact that 
TrmD proteins from bacteria which have been 
shown to produce 3’,5’-cAMP (E. coli and M. 
tuberculosis) do not bind 3’,5’-cAMP with high 
affinity, whereas TrmD from S. aureus tightly 
binds 3’,5’-cAMP raises the possibility that TrmD 
has evolved immunity to 3’,5’-cAMP in bacteria 
producing this signaling nucleotide. To test this 
hypothesis, the phylogeny of TrmD was analyzed 
and compared with that of adenylate cyclases. To 
do this, we searched for homologs of S. aureus 
TrmD in the 555 complete bacterial and archaeal 
proteomes used by Galperin and collaborators 
((11) Table S1). BLASTP queries identified a total 
of 503 homologs with a large taxonomic 
distribution. Specifically, homologues are found in 
one copy in all bacterial phyla (except for 
Syntrophobacter fumaroxidans MPOB that have 
two TrmD proteins: YP_847151 and YP_847109, 
Table S1). Close homologs are absent from 
Archaea, consistent with previous report that 
TrmD from Archaea is more similar to Eukaryotic 
counterparts. A phylogenetic tree of TrmD 
homologs was built (Fig. S1) as well as all 
sequences were aligned and careful inspection of 
the alignment showed that motifs B and C of the 
AdoMet binding site are well conserved among all 
TrmD homologs (Fig. S2). However, the first three 
residues of motif A are variable (Figs. S2). Based 
on the data of Galperin and collaborators 
concerning the presence/absence of adenylate 
cyclase in bacterial proteomes there appears to be 
a positive correlation between the presence or 
absence of ACs (and therefore ability of bacteria to 
produce 3’,5’-cAMP) and the divergence of the 
first three residues of A motif in TrmD proteins, 
especially in γ-proteobacteria and Firmicutes 
(Figs. 7 and S2). In fact, in the proteomes where 
an AC is present (such as in E. coli), the first 
residue of motif A is predominantly a 
tyrosine/phenylalanine (49.62% of the cases). 
However, in the proteomes where an AC is absent 
(such as in S. aureus) the first residue in motif A is 
in a large number of cases a leucine (46.08% of 
the cases). In particular for Firmicutes bacteria, 
there appears to be a good correlation between the 
absence and presence of a tyrosine/phenylalanine 
residue in the first position of TrmD motif A1 and 
the absence and presence of an AC in an organism 
(Fig. 7D). Taken together, this indicates an 
underlying evolutionary pressure and protein 
evolution to prevent the binding of 3’,5’-cAMP to 
TrmD in organisms utilizing this cyclic-nucleotide 
as signalling molecule.  
DISCUSSION 
Evidence whether or not the signaling nucleotide 
3’,5’-cAMP is present in many of the well-studied 
Firmicutes such as S. aureus has been elusive. In 
this study, the S. aureus TrmD protein was 
identified as a 3’,5’-cAMP-binding protein and 
3’,5’-cAMP seems to bind competitively and with 
high affinity at the AdoMet substrate binding 
pocket (Fig. 1A and 1B). However, using an LC-
MS/MS analysis of bacterial extracts and based on 
other biochemical assays, we were unable to detect 
3’,5’-cAMP or an active adenylate cyclase in S. 
aureus (Figs. 2 and 3). 3’,5’-cAMP is thus unlikely 
to be present in S. aureus. On the other hand, we 
found that TrmD proteins from the γ-
proteobacterium E. coli and the Actinobacterium 
M. tuberculosis do not bind 3’,5’-cAMP with high 
affinity. Subsequent bioinformatics, mutagenesis 
and biochemical analyses demonstrated that 
residue Tyr86 in E. coli TrmD plays a pivotal role 
in discriminating between 3’,5’-cAMP and the 
native substrate AdoMet. A further phylogenetic 
analysis suggests that amino acids in the substrate 
binding pocket of TrmD underwent an adaptive 
evolution to accommodate the presence of 
adenylate cyclases and the 3’,5’-cAMP signaling 
molecule.  
Several lines of evidence argue for the 
absence of 3’,5’-cAMP in S. aureus and likely also 
in many other Firmicutes bacteria. The major 
function of 3’,5’-cAMP in bacteria, the carbon 
catabolite repression, is executed through a 
modified pathway in several of the model 
Firmicutes bacteria (Bacillus, Listeria and 
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Staphylococcus) (2). While CRP-like transcription 
factors are present in Firmicutes, they often lack 
key residues known to be required for the binding 
of 3’,5’-cAMP (14). As shown in this study, ArcR, 
a CRP-family transcriptional factor in S. aureus, 
does not bind 3’,5’-cAMP as determined by 
DRaCALA (Fig. 1C). Using a very sensitive LC-
MS/MS based method, 3’,5’-cAMP could not be 
detected in S. aureus extracts prepared from 
cultures grown under several different conditions 
including micro-aerobic and catabolite repression 
conditions, where 3’,5’-cAMP was believed to be 
produced (Fig. 2) (12,13). In vitro and in vivo 
experiments on the predicted adenylate cyclase 
SAUSA300_0905 (SACOL1008) enzyme, 
indicated that this protein is not a genuine 
adenylate cyclase as this protein does not 
hydrolyze ATP nor produce 3’,5’-cAMP (Figs. 3A, 
3B). Close homologues to SAUSA300_0905 are 
found in many other bacteria belonging to the 
Firmicutes group. Despite the fact that this protein 
likely has a similar overall fold as type IV ACs, we 
identified in our bioinformatics analysis, distinct 
sequence features in SAUSA300_0905 and its 
homologs compared to bona fide Class IV ACs 
(Fig. 4A). The physiological function of 
SAUSA300_0905, its enzymatic activity and 
substrate specificity remain to be studied.  
A genome wide DRaCALA screen for 
3’,5’-cAMP binding proteins using an S. aureus 
ORFeome library identified the essential tRNA 
methyltransferase TrmDSA as 3’,5’-cAMP binding 
protein (Fig. 1A). 3’,5’-cAMP binds with high 
affinity to TrmDSA and competes for the binding 
with the native substrate AdoMet (Fig. 1A). The 
difference in binding affinity is indicated by the 
limited capacity of AdoMet to compete with 3’,5’-
cAMP for binding to TrmDSA (Fig. 1B). Given that 
TrmD binds its substrate tRNA species in an 
AdoMet dependent manner (16), this difference in 
binding affinity suggests a potential inhibitory 
effect on the essential function of TrmD would 
3’,5’-cAMP be present in S. aureus. As shown in 
this work, a tyrosine residue found at position 86 
in the E. coli TrmD and highly conserved among 
TrmD proteins from γ-proteobacteria, aids in the 
discrimination and preferential binding of AdoMet 
over 3’,5’-cAMP in E. coli (Fig. 6A and 7). This 
residue is absent in S. aureus and most other 
Fimicutes (Fig. 6A and 7A). However, some non-
type Firmicutes strains, which are predicted to 
encode a genuine adenylate cyclase (11), such as 
Clostridium acetobutylicum ATCC 824, 
Clostridium perfringens str. 13,  
Caldicellulosiruptor saccharolyticus DSM 8903, 
Desulfotomaculum reducens MI-1, 
Natranaerobius thermophilus JW/NM-WN-LF 
and their sub-strains, contain a Tyr or Phe residue 
at this position, suggesting a coupling of the 
presence of a functional adenylate cyclase and 
3’,5’-cAMP production with the presence of a Y/F 
amino acid reside at this position (Fig. 7D). 
Altogether the findings presented in this study, 
strongly suggest that 3’,5’-cAMP and a functional 
adenylate cyclase enzyme are absent in S. arueus 
and, while not all, likely also a large number of 
other bacteria belonging to the Firmicutes group. 
TrmD is a highly conserved tRNA 
methyltransferase found in all three domains of 
life that converts G37 into m1G37 by transferring 
the methyl group from AdoMet to a subset of 
tRNA species (15,32). This modification on 
tRNAs is essential for maintaining the correct 
reading frame during protein translation (15,33). 
Abolishing the function of TrmD increases +1 
frame shift events during protein translation and 
growth defects have been observed in its absence 
in bacteria and yeast (15,33-35). In order to bind 
the AdoMet substrate, TrmD proteins assumes a 
particular protein fold composed of a deep trefoil 
knot that is a characteristic of SPOUT family RNA 
methyltransferases (MTases). SPOUT family 
MTases methylate ribosomal RNAs or tRNAs on a 
base or ribose ring using AdoMet as the methyl 
donor (36). The conserved AdoMet binding site 
and unique protein fold of SPOUT MTases raises 
the question as to why other MTases from S. 
aureus were not identified as 3’,5’-cAMP binding 
proteins. Several MTases have been crystalized in 
complex with AdoMet, its analogue sinefungin or 
S-adonesyl-L-homocysteine (AdoHcy) (29,37-39). 
Careful inspection of the substrate binding sites of 
these other MTases, namely the tRNA MTases 
TrmL (PDB code 1MXI), TrmH (PDB code 
1V2X), MjNep1 (PDB code 3BBH) and the rRNA 
MTases ScNep1 (PDB code 2V3K), RsmE (PDB 
code 2Z0Y) (Fig. 8), revealed that in these cases a 
main chain peptidyl amine of a highly conserved 
glycine residue forms hydrogen bonds with the 2’- 
and 3’-OH of AdoMet/AdoHcy/sinefungin. This 
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difference might explain why only TrmDSA was 
found to interact with 3’,5’-cAMP as other MTases 
in S. aureus are likely able to discriminate between 
3’,5’-cAMP and AdoMet.  
In γ-proteobacteria and Firmicutes, we 
found bioinformatically and experimentally a good 
correlation between the ability of TrmD proteins to 
discriminate between 3’,5’-cAMP and AdoMet 
and the presence of a tyrosine or phenylalanine 
residue at a position equivalent to position 86 in 
the E. coli TrmD protein (Figs. 6 and 7). These 
data suggest that TrmD proteins in bacteria 
producing 3’,5’-cAMP adapted to confer 
“immunity” to 3’,5’-cAMP, binding of which 
would otherwise inhibit the essential function of 
TrmD. However, this simple correlation was not 
obvious in all groups of bacteria. In particular, we 
found that TrmD proteins from the Actinobacteria 
group had a unique set of highly conserved amino 
acid residues VPT in the motif A1 (Fig. 6A). 
Considering the numerous adenylate cyclases 
reported in this group of bacteria (up to 16 ACs in 
M. tuberculosis) (1), it is possible that the TrmD 
proteins underwent a global whole-protein 
adaption and optimization to properly function in 
the unique physiological conditions imposed by 
these ACs. It remains to be investigated how these 
“unusual” TrmD proteins cope with the presence 
of physiological concentrations of 3’,5’-cAMP. 
Such studies could also have translational impact 
as TrmD proteins from bacteria are distinct from 
those found in Eukaryotes and Archaea and thus 
remain attractive drug targets. 
TrmD has been extensively studied, 
especially in pathogenic bacteria, where a number 
of biochemical and structural characterization 
were performed (16,29) in order to pinpoint 
unique features that are drug-able. Indeed, the 
TrmDMT protein was highlighted as an excellent 
drug target candidate in M. tuberculosis (40) and 
screens for small molecule TrmD enzyme inhibitor 
were performed (41,42). Lahoud et al. (42) found 
that adenosine and methionine fragments of 
AdoMet, preferentially inhibit bacterial TrmD 
proteins over those of Eukaryotic-Archaea origins. 
Hill et al. (41) screened a large collection of 
compounds and following further compound 
optimization TrmD–specific inhibitor with 
nanomolar affinities were identified. In our study, 
we surprisingly found that the second message 
3’,5’-cAMP, a chemical analogue to AdoMet, 
specifically binds with a high affinity to TrmD 
from S. aureus and probably also several other 
Firmicutes group of bacteria, and could therefore 
also function as inhibitor in these bacteria.  
In conclusion, this study provided several 
lines of evidence against the existence of 3’,5’-
cAMP in S. aureus and, while not all, probably 
also many other Firmicutes. More importantly, 
TrmDSA was found to bind 3’,5’-cAMP with high 
affinity, probably due to its chemical similarity to 
the native substrate AdoMet, while TrmD proteins 
from γ-proteobacteria evolved to contain a Y/F 
residue at position 86, which confers “immunity” 
to a potentially detrimental effect of binding 3’,5’-
cAMP. These findings provide a potential 
opportunity to develop drugs specifically targeting 
a number of pathogenic bacteria belonging to the 
Firmicutes, which would be especially important 




Bacterial growth conditions - Escherichia coli 
strains were grown in Luria Bertani (LB). LB-M9 
medium (49.3 mM Na2HPO4, 14.7 mM KH2PO4, 
8.55 mM NaCl, 18.7 mM NH4Cl, 3.7 mM Na 
succinate, 11.1 mM glucose, 2 mM MgSO4, 1% 
tryptone and 0.5% yeast extract) was used for the 
growth of the E. coli S. aureus ORFeome library 
strains. S. aureus strains were grown in Tryptic 
Soy Broth (TSB) medium or B-medium (1% 
peptone, 0.5% yeast extract, 0.5% NaCl, 0.1% 
KH2PO4) supplemented with 25 mM of glucose or 
sucrose (25). For micro-aerobic growth of S. 
aureus, cells were inoculated into 50 ml Falcon 
tubes filled up completely with TSB medium and 
incubated at 37oC without agitation (43). Micro-
aerobic growth was validated by adding 0.001% 
Resazurin (Sigma) to the cultures as a redox 
indicator. When appropriate, cultures were 
supplemented with antibiotics indicated in Table 1. 
Strain and plasmid constructions – Bacterial 
strains and primers used in this study are listed in 
Table 1 and Table 2, respectively. For construction 
of plasmids pET28b-His-trmDEC and pET28b-His-
trmDSA primer pairs ANG1918/1919 and 
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ANG1920/1921 were used to amplify the trmD 
genes using E. coli MG1655 or S. aureus LAC* 
chromosomal DNA as template. The PCR products 
were digested with NheI/EcoRI and ligated with 
plasmid pET28b that has been cut with the same 
enzymes. For construction of plasmids pET28b-
His-trmDEC(Y86F) and pET28b-His-
trmDEC(Y86L) primer pairs ANG1918/2152, 
ANG1919/2153 and ANG1918/2154, 
ANG1919/2155 were used in the first round of 
PCR. The resulting products were gel purified and 
fused using primer pair ANG1918/1919. The final 
product was digested with NheI and EcoRI, and 
ligated with plasmid pET28b that has been cut 
with the same enzymes. Plasmid pET28b-His-
trmDSA(LMC-YLS) was constructed in a similar 
manner using primers ANG1920/2156 and 
ANG1921/2157 in the first PCR and primers 
ANG1920/1921 in the second PCR. The final 
product was digested with enzymes NheI and 
EcoRI and ligated with plasmid pET28b. For 
construction of plasmid pET23b-His-trmDTB, 
primer pair ANG2158/2159 and M. tuberculosis 
H37Rv chromosomal DNA was used to amplify 
the trmDTB gene. The PCR product was digested 
with NdeI and HindIII and ligated with plasmid 
pET23b that has been cut with the same enzymes. 
For construction of plasmid pET28b-His6-
cyaAEC(2-446) primer pair ANG1788/1789 and E. 
coli MG1655 chromosomal DNA were used. The 
PCR product was digested with NheI and EcoRI 
and ligated with plasmid pET28b. For construction 
of plasmids pBAD33-cyaAEC(2-446)-His6 and 
pBAD33-SAUSA300_0905-His6 primer pairs 
ANG2003/2004 and ANG2005/2006 were used to 
amplify the cyaA or SAUSA300_0905 gene using 
E. coli MG1655 and S. aureus LAC* 
chromosomal DNA, respectively. The PCR 
products were digested with KpnI and XbaI and 
ligated with plasmid pBAD33 that has been cut 
with the same enzymes. All plasmids were initially 
recovered in E. coli strain XL-1 Blue and 
sequences of inserts confirmed by fluorescent 
automated sequencing (GATC Biotech). For 
protein expression and purification, the plasmids 
were introduced in E. coli strain BL21(DE3), 
yielding the strains as specified in Table 1. 
Protein expression and purification – E. coli 
BL21(DE3) strains (Table 1) were used for the 
expression and purification of His-CyaAEC(2-446), 
the His-tagged TrmD proteins and its variants. 1 L 
cultures of the different strains were grown at 
37oC to an OD600 of 0.5 to 0.7 and protein 
expression induced with 0.5 mM IPTG and 
cultures incubated overnight at 18oC. For 
purification of His6-SACOL1008 and His6-
SACOL2653, strain T7IQ containing plasmids 
pVL791-His6-SACOL1008 and pVL791-His6-
SACOL2653 were grown at 30oC overnight. The 
next day, the cultures were diluted 1:50 into 1 L of 
fresh LB medium, and incubated for 4 h at 30oC 
and subsequently protein expression induced with 
1 mM IPTG for 4 h. Protein purifications by Ni-
NTA affinity chromatography and size exclusion 
chromatography were performed as previously 
described (44). Protein containing fractions were 
pooled and concentrated to around 10 mg/ml using 
10 kDa cut-off centrifugal filters. Protein 
concentrations were determined using the BCA 
Protein assay kit from Pierce. The purity of the 
purified proteins was assessed on coomassie 
stained gels following separation of the indicated 
amount of protein on 12% SDS-PAGE gels. 
Synthesis of 32P 3’,5’-cAMP - 32P-labeled 3’,5’-
cAMP was synthesized from α-32P-ATP (Perkin 
Elmer) by incubating 55.5 nM α-32P-ATP with 20 
µM of purified His-CyaAEC(2-446) protein in 40 
mM Tris pH 7.5, 100 mM NaCl, 10 mM MgCl2 
buffer overnight at 37°C. The sample was 
subsequently incubated for 10 min at 95°C and the 
denatured His-CyaAEC(2-446) protein removed by 
centrifugation at 17,000 x g for 5 min, the 
supernatant transferred to a new tube and stored at 
-20oC. The conversion of α-32P-ATP to 32P-α-
cAMP was estimated to be at least 97%, as 
assessed by thin layer chromatography (TLC) 
using H2O/ethanol/ammonium bicarbonate 
(30%:70%:0.2 M) as the mobile phase and 
densitometry analysis, which was performed as 
described previously (18).  
 
Differential radial capillary action of ligand assay 
and screen for 3’,5’-cAMP binding proteins – An 
S. aureus ORFeome library allowing the 
expression of 2,337 N-terminally His-MBP-tagged 
S. aureus strain COL proteins in E. coli, was 
utilized to identify potential 3’,5’-cAMP target 
proteins. The construction and use of this 
ORFeome library has been described previously 
(19,20). Protein expression and the preparation of 
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whole cell lysates and the subsequent differential 
radial capillary action of ligand assay (DRaCALA) 
were performed as previously, with the 
modification that 32P-labeled 3’,5’-cAMP was 
used as nucleotide ligand (17-19). For the 
determination of Kd values by DRaCALA, two-
fold serial dilutions of purified His-TrmDSA, His-
TrmDEC, His-TrmDTB or the different variants 
were prepared in binding buffer (40 mM Tris pH 
7.5, 100 mM NaCl, 10 mM MgCl2), starting at a 
concentration of 200 µM and subsequently mixed 
with approximately 2 nM 32P-labeled 3’,5’-cAMP. 
The mixtures were incubated for 5 min at room 
temperature before spotting 2.5 µl of the reactions 
on nitrocellulose membranes (Amersham Hybond-
ECL; GE Healthcare). The fraction of ligand 
bound and Kd values were calculated as previously 
described (17). For nucleotide competition assays, 
the specified purified protein at a final 
concentration of 100 µM was incubated with 
approximately 2 nM 32P-labeled 3’,5’-cAMP in the 
presence of 400 µM of the competitor nucleotides 
AdoMet, 3’,5’-cAMP, 3’,5’-cGMP, c-di-AMP, c-
di-GMP, ATP, ADP, AMP or 2’3’-cAMP. The 
reactions were incubated for 5 min at room 
temperature, 2.5 µl spotted onto nitrocellulose 
membranes and fraction bound values determined 
as described above. 
In vitro adenylate cyclase assay – The purified 
His6-SACOL1008 protein was tested for potential 
adenylate cyclase activity using previously 
described in vitro assay systems (8,26). The 
purified His-CyaAEC(2-446) protein was used as 
positive control and enzyme assays were set up in 
three different buffer systems. Buffer 1 consisted 
of 40 mM Tris pH 7.5, 100 mM NaCl, 10 mM 
MgCl2, and was previously used to measure the 
activity of the E. coli CyaA enzyme (26). Buffer 2 
consisted of 50 mM Tris pH 8.8, 20 mM MgCl2, 1 
mM DTT and buffer 3 is similar to buffer 2 but 
replacing the 10 mM MnCl2 with 10 mM MgCl2. 
Buffers 2 and 3 have been previously used to 
assess the activity of type IV ACs (8). 4 µM of 
purified protein was used in a 10 µl reaction 
volume with 333.3 nM α-32P-ATP added. The 
reactions were incubated at 37oC for 1 h or 
overnight, heat inactivated and subsequently 
analyzed by TLC as described above. 
In vivo adenylate cyclase activity assay – The 
ability of SAUSA300_0905 (SACOL1008 
homolog) to synthesize 3’5’-cAMP in E.coli was 
tested by introducing the plasmid pBAD33-
SAUSA300_0905-His6 into the E. coli cyaA 
mutant strain DHM1. Plasmids pBAD33-
cyaAEC(2-446)-His6 and pBAD33 were also 
introduced into strain DHM1, and the resulting 
strains used as positive and negative controls, 
respectively. After transformation into DHM1, 
about 30 colonies from each transformation plate 
were inoculated into LB medium and incubated at 
37oC overnight. The next morning, they were sub-
cultured in fresh LB-medium at 37oC and grown to 
an OD600 of about 0.5. One ml of each culture was 
harvested and adjusted to OD600 = 5 and 5 µl 
spotted on LB-plates supplemented with 0.02% 
arabinose and 40 µg/ml X-gal and the appropriate 
antibiotics. Plates were incubated overnight at 
37oC and photos taken with a Nikon camera. 
Preparation of cell extract and detection of 
nucleotides by LC-MS/MS – S. aureus strains JE2 
and JE2 Tn::SAUSA300_0905 (NE1299, 
ANG3894) were grown overnight in TSB medium 
as well as in B-medium supplemented with 25 mM 
of either glucose or sucrose (for stationary phase 
samples). Next day, cultures were also back-
diluted 1:50 into fresh medium and incubated for 3 
h at 37oC (for exponential phase samples). 
Bacterial cells corresponding to 1 ml culture of 
OD600 = 10 were harvested by centrifugation and 
cell extracts for LC-MS/MS analysis prepared as 
described below. For cells grown under micro-
aerobic conditions, overnight cultures were diluted 
1:50 into 50-ml Falcon tubes filled up to the top 
with fresh TSB medium, and incubated at 37oC 
without agitation for 24 or 48 h (for exponential 
and post-exponential phase samples). To ensure 
that the bacteria did not aerobically respire under 
these growth conditions, resazurin was added to 
the cultures at a final concentration of 0.001% w/v 
as previously described (43). The reduction 
potential of resazurin at pH 7.0 and 25oC is +380 
mV, sitting between oxygen gas (+820 mV) and 
cytochromes (+290 to +80). This makes this 
compound suitable for detecting aerobic 
respiration activity or lack thereof, as the former 
would lead to the reduction of resazurin to 
resorufin and a blue to pink color change (45). 
Next, bacteria were collected by centrifugation, 
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and the pellets suspended immediately in 1 ml of 
nucleotide extraction buffer containing 
acetonitrile–methanol–water (2:2:1, v/v) and 
heated for 15 min at 95oC to minimize the effect of 
oxygen on the cell physiology and metabolites. Six 
samples were prepared for each culture condition 
for strains JE2 and JE2 Tn::SAUSA300_0905. For 
three of these samples the extraction buffer was 
spiced with 92.8 ng/ml isotope labeled 3’,5’-
cAMP. To generate the isotope labeled 3’,5’-
cAMP, 5 mM 13C,N15-ATP was converted into 
13C,N15-cAMP with 5 µM E. coli CayA(2-446) 
in 40 mM Tris pH7.5, 100 mM NaCl, 10 mM 
MgCl2 buffer and the sample was incubated at 
37oC overnight. The conversion rate was 
determined as 93.4% by LC-MS/MS analysis. S. 
aureus extracts were prepared and 3’,5’-cAMP and 
2’,3’-cAMP detected by LC-MS/MS as described 
previously (24). 
Kd determination by Isothermal Titration 
Calorimetry (ITC) – A MicroCal iTC200 
instrument (GE Healthcare) was used to determine 
the disassociation constants of 3’5’-cAMP or 
AdoMet and the E. coli or S. aureus wild-type 
TrmD proteins or TrmD variants. To minimize the 
dilution effect, the purified TrmD proteins were 
dialysed for 24 h at 4oC against 4 L of binding 
buffer (40 mM Tris pH 7.5, 100 mM NaCl, 10 mM 
MgCl2, 5% v/v glycerol). Subsequently, the 
samples were spun down at 17,000 x g at 4oC for 
10 min to remove any insoluble material, the 
supernatant transferred to new tubes and the 
protein concentrations measured using a BCA 
assay kit (Pierce). An aliquot of the dialysis buffer 
was used to make 1 mM 3’5’-cAMP and AdoMet 
solutions and also used to set the TrmD proteins to 
a concentration of 100 µM. After initial trials, the 
MicroCal iTC200 was set to a reference power of 
6 µcal/sec, a stirring speed of 500 rpm, 
temperature of 25oC and 20 injections at 180 sec 
intervals. At least two technical replicates were 
performed with each TrmD protein. As negative 
control, the ligands were titrated against the 
dialysis buffer, and the obtained values subtracted 
from the experimental data. Curve fitting, data 
analysis and Kd calculations were performed using 
the Origin program. 
Western blot – The expression of 
SAUSA300_0905-His6 and CyaAEC(2-446)-His6 
from the pBAD33 vectors in DHM1 was 
confirmed by western blot. Briefly, cultures of 
strain DHM1 containing the different pBAD33-
derived vectors were grown overnight in LB 
medium at 30oC. Next day, the overnight cultures 
were induced with 0.02% arabinose for 3 h. 
Bacteria from 1 ml culture aliquots before and 
after the induction were collected by 
centrifugation, cells suspended in 1 x SDS sample 
buffer to get a final OD600nm of 40. Samples were 
heated for 10 min at 95oC and proteins separated 
on a 12% SDS-PAGE gel. Proteins were then 
transferred to a PVDF membrane and His-tagged 
proteins detected using a monoclonal anti-poly-
His-peroxidase antibody (Sigma A-7058). 
Sequence and structure analysis – Homologs of 
the S. aureus protein SAUSA300_0905, the Y. 
pestis CyaB protein and the TrmD proteins from 
E. coli, S. aureus and M. tuberculosis proteins 
were identified as follows: For SAUSA300_0905 
and CyaB from Y. pestis, the respective protein 
sequences were used as query sequences in 
BLASTP searches in the NCBI non-redundant (nr) 
protein sequence database using default settings. 
For the TrmD proteins, the respective protein 
sequences were used as query sequence in a 
BLASTP search confined to their respective 
groups of bacteria, namely E. coli TrmD for γ-
proteobacteria, M. tuberculosis TrmD for 
Actinobacteria and S. aureus TrmD for Firmicutes. 
Subsequently, the identified protein homologs with 
a maximum expect (e) values below 3e-04 and a 
minimum sequence coverage and sequence 
identity of 60% and 30%, respectively, were 
retrieved and used for further analysis in Jalview 
(28). A multi-sequence alignment was generated 
for each group of proteins by running 20 iterations 
and a conserved logo-sequence generated with 
Cluster Omega (46). To compare the sequences of 
the SAUSA300_0905 and CyaB homologs or the 
E. coli, S. aureus and M. tuberculosis TrmD 
homologs, the respective groups of sequences 
were combined and a multi-sequence alignment 
and/or a logo-sequence generated as described 
above. A multiple sequence alignment of all TrmD 
proteins was also generated and subsequently used 
as input sequence on the ConSurf server, to 
visualize the AdoMet binding site in a structural 
context (31). To this end, chain A of the AdoMet-
bound H. influenza TrmD protein was used as 
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structural template (PDB code 1UAK). Pymol 
(v1.7.4.4 Edu Enhanced for Mac OS X, 
Schrödinger, LLC.) was used to display the 
ConSurf data and also for the structural 
comparison of the AdoMet binding site of the S. 
aureus TrmD (PDB code 3KY7) and H. influenza 
TrmD (PDB code 1UAK) proteins. A structural 
model of SAUSA300_0905 was generated in 
Phyre2 (47) and viewed in Pymol. 
 
Phylogeny analysis of TrmD and adenylate 
cyclases – A local protein database containing the 
555 complete bacterial and archaeal proteomes 
used by Galperin and collaborators in his study on 
the distribution of bacterial signal transduction 
systems (11) was built. This database was queried 
with the BLASTP program (default parameters, 
(48)) using the full length sequence of TrmD 
protein of S. aureus subsp. aureus N315 as a seed 
(Ref_seq: NP_374356, Locus_tag: SA1083). The 
distinction between homologous and non-
homologous sequences was assessed by visual 
inspection of the BLASTP output (no arbitrary 
cut-offs on E-value or score). To ensure the 
exhaustive sampling of homologs, iterative 
BLASTP queries were performed using homologs 
identified at each step as new seeds. The absence 
of a homolog in any complete proteome in the 
local database was systematically verified by 
TBLASTN queries against the nucleotide 
sequence of the corresponding genome. For each 
candidate protein, the retrieved homologs were 
added to the dataset. The retrieved sequences were 
aligned using MAFFT v7.045b (default 
parameters, (49)). Regions where the homology 
between amino acid positions was doubtful were 
removed using the BMGE software (BLOSUM30 
option, (50)). Bayesian analyses were performed 
using MrBayes version 3.2.2 (51) with a mixed 
model of amino acid substitution including a 
gamma distribution (4 discrete categories) and an 
estimated proportion of invariant sites. MrBayes 
was run with four chains for 1 million generations 
and trees were sampled every 100 generations. To 
construct the consensus tree, the first 2000 trees 
were discarded as “burn in” (51). The Sequence-
logos of TrmD the alignments were generated 
using Phylo-mLogo visualization tool in order to 





Footnotes: This work was funded by the Wellcome Trust grant 100289 and the European research council 
grant 260371 to A.G. and the EMBO long-term fellowship ALTF 721-2013 to Y.Z.  
Acknowledgment: We would like to thank Geralad Larrouy-Maumus for providing M. tuberculosis 
H37Rv chromosomal DNA, Annette Garbe for the nucleotide analysis by mass spectrometry and Mark 
Bennet for the preliminary analysis of 2’3’-cAMP by mass spectrometry. We would also like to thank 
Steven Harre for assistance with the ITC experiments. 
Conflict of interest: The authors declare that they have no conflict of interest with the contents of this 
article. 
Author contribution: Y.Z. and A.G. designed the study and acquired funding and wrote the manuscript; 
Y.Z. and L.E.B acquired experimental data, Y.Z. and R.A. performed the bioinformatics analyses, Y.Z., 
R.A., L.E.B., J.C., V.K. and A.G. analyzed the data. 
 
  
 	 14 
REFERENCES 
1. Gancedo, J. M. (2013) Biological roles of cAMP: variations on a theme in the different kingdoms 
of life. Biol. Rev. 88, 645-668 
2. Goerke, B., and Stülke, J. (2008) Carbon catabolite repression in bacteria: many ways to make the 
most out of nutrients. Nat. Rev. Microbiol. 6, 613-624 
3. Cotta, M. A., Whitehead, T. R., and Wheeler, M. B. (1998) Identification of a novel adenylate 
cyclase in the ruminal anaerobe, Prevotella ruminicola D31d. FEMS Microbiol. Lett. 164, 257-
260 
4. Tellez-Sosa, J., Soberon, N., Vega-Segura, A., Torres-Marquez, M. E., and Cevallos, M. A. (2002) 
The Rhizobium etli cyaC product: Characterization of a novel adenylate cyclase class. J. 
Bacteriol. 184, 3560-3568 
5. Ahuja, N., Kumar, P., and Bhatnagar, R. (2004) The adenylate cyclase toxins. Crit. Rev. 
Microbiol. 30, 187-196 
6. Bettendorff, L., and Wins, P. (2013) Thiamine triphosphatase and the CYTH superfamily of 
proteins. FEBS J. 280, 6443-6455 
7. Iyer, L. M., and Aravind, L. (2002) The catalytic domains of thiamine triphosphatase and CyaB-
like adenylyl cyclase define a novel superfamily of domains that bind organic phosphates. BMC 
Genomics 3 
8. Gallagher, D. T., Kim, S. K., Robinson, H., and Reddy, P. T. (2011) Active-Site Structure of Class 
IV Adenylyl Cyclase and Transphyletic Mechanism. J. Mol. Biol. 405, 787-803 
9. Delvaux, D., Murty, M. R. V. S., Gabelica, V., Lakaye, B., Lunin, V. V., Skarina, T., Onopriyenko, 
O., Kohn, G., Wins, P., De Pauw, E., and Bettendorff, L. (2011) A Specific Inorganic 
Triphosphatase from Nitrosomonas europaea : structure and catalytic mechanism. J. Biol. Chem. 
286, 34023-34035 
10. Gallagher, D. T., Smith, N. N., Kim, S. K., Heroux, A., Robinson, H., and Reddy, P. T. (2006) 
Structure of the class IV adenylyl cyclase reveals a novel fold. J. Mol. Biol. 362, 114-122 
11. Galperin, M. Y., Higdon, R., and Kolker, E. (2010) Interplay of heritage and habitat in the 
distribution of bacterial signal transduction systems. Mol. Biosys.t 6, 721-728 
12. Mach, H., Hecker, M., and Mach, F. (1984) Evidence for the Presence of Cyclic Adenosine-
Monophosphate in Bacillus subtilis. FEMS Microbiol. Lett. 22, 27-30 
13. Mach, H., Hecker, M., and Mach, F. (1988) Physiological-studies on cAMP synthesis in Bacillus 
subtilis. FEMS Microbiol. Lett. 52, 189-192 
14. Makhlin, J., Kofman, T., Borovok, I., Kohler, C., Engelmann, S., Cohen, G., and Aharonowitz, Y. 
(2007) Staphylococcus aureus ArcR controls expression of the arginine deiminase operon. J. 
Bacteriol. 189, 5976-5986 
15. Urbonavicius, J., Qian, O., Durand, J. M. B., Hagervall, T. G., and Bjork, G. R. (2001) 
Improvement of reading frame maintenance is a common function for several tRNA 
modifications. EMBO J. 20, 4863-4873 
16. Itoa, T., Masuda, I., Yoshida, K. I., Goto-Ito, S., Sekinea, S. I., Suh, S. W., Houd, Y. M., and 
Yokoyama, S. (2015) Structural basis for methyl-donor-dependent and sequence-specific binding 
to tRNA substrates by knotted methyltransferase TrmD. Proc. Natl. Acad. Sci. USA 112, E4197-
E4205 
17. Roelofs, K. G., Wang, J. X., Sintim, H. O., and Lee, V. T. (2011) Differential radial capillary 
action of ligand assay for high-throughput detection of protein-metabolite interactions. Proc. 
Natl. Acad. Sci. USA 108, 15528-15533 
18. Corrigan, R. M., Campeotto, I., Jeganathan, T., Roelofs, K. G., Lee, V. T., and Gründling, A. 
(2013) Systematic identification of conserved bacterial c-di-AMP receptor proteins. Proc. Natl. 
Acad. Sci. USA 110, 9084-9089 
19. Corrigan, R. M., Bellows, L. E., Wood, A., and Gründling, A. (2016) ppGpp negatively impacts 
ribosome assembly affecting growth and antimicrobial tolerance in Gram-positive bacteria. Proc. 
Natl. Acad. Sci. USA 113, E1710-1719 
 	 15 
20. Schuster, C. F., Bellows, L. E., Tosi, T., Campeotto, I., Corrigan, R. M., Freemont, P., and 
Gründling, A. (2016) The second messenger c-di-AMP inhibits the osmolyte uptake system OpuC 
in Staphylococcus aureus. Sci. Signal. 9, ra81 
21. Harman, J. G., and Dobrogosz, W. J. (1983) Mechanism of Crp-mediated Cya suppression in 
Escherichia coli. J. Bacteriol. 153, 191-199 
22. Jackson, E. K. (2011) The 2 ',3 '-cAMP-adenosine pathway. Am. J. Physiol. Renal Physiol. 301, 
F1160-F1167 
23. Van Damme, T., Blancquaert, D., Couturon, P., Van der Straeten, D., Sandra, P., and Lynen, F. 
(2014) Wounding stress causes rapid increase in concentration of the naturally occurring 2 ',3 '-
isomers of cyclic guanosine- and cyclic adenosine monophosphate (cGMP and cAMP) in plant 
tissues. Phytochemistry 103, 59-66 
24. Bähre, H., and Kaever, V. (2014) Measurement of 2 ',3 '-cyclic nucleotides by liquid 
chromatography-tandem mass spectrometry in cells. J. Chromatogr. B Analyt. Technol. Biomed. 
Life Sci. 964, 208-211 
25. Jankovic, I., and Brucker, R. (2007) Carbon catabolite repression of sucrose utilization in 
Staphylococcus xylosus : Catabolite control protein CcpA ensures glucose preference and 
autoregulatory limitation of sucrose utilization. J. Mol. Microb. Biotech. 12, 114-120 
26. Linder, J. U. (2008) Structure-function relationships in Escherichia coli adenylate cyclase. 
Biochem. J. 415, 449-454 
27. Sismeiro, O., Trotot, P., Biville, F., Vivares, C., and Danchin, A. (1998) Aeromonas hydrophila 
adenylyl cyclase 2: a new class of adenylyl cyclases with thermophilic properties and sequence 
similarities to proteins from hyperthermophilic archaebacteria. J. Bacteriol. 180, 3339-3344 
28. Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M., and Barton, G. J. (2009) Jalview 
Version 2: a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 
1189-1191 
29. Ahn, H. J., Kim, H. W., Yoon, H. J., Lee, B. I., Suh, S. W., and Yang, J. K. (2003) Crystal 
structure of tRNA(m(1)G37)methyltransferase: insights into tRNA recognition. EMBO J. 22, 
2593-2603 
30. Elkins, P. A., Watts, J. M., Zalacain, M., van Thiel, A., Vitazka, P. R., Redlak, M., Andraos-Selim, 
C., Rastinejad, F., and Holmes, W. M. (2003) Insights into catalysis by a knotted TrmD tRNA 
methyltransferase. J. Mol. Biol. 333, 931-949 
31. Ashkenazy, H., Erez, E., Martz, E., Pupko, T., and Ben-Tal, N. (2010) ConSurf 2010: calculating 
evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids 
Res. 38, W529-533 
32. Bystrom, A. S., and Bjork, G. R. (1982) The structural gene (trmD) for the 
tRNA(m1G)methyltransferase is part of a four polypeptide operon in Escherichia coli K-12. Mol. 
Gen. Genet. 188, 447-454 
33. Bjork, G. R., Wikstrom, P. M., and Bystrom, A. S. (1989) Prevention of translational 
frameshifting by the modified nucleoside 1-methylguanosine. Science 244, 986-989 
34. Hagervall, T. G., Tuohy, T. M., Atkins, J. F., and Bjork, G. R. (1993) Deficiency of 1-
methylguanosine in tRNA from Salmonella typhimurium induces frameshifting by quadruplet 
translocation. J. Mol. Biol. 232, 756-765 
35. Bjork, G. R., and Nilsson, K. (2003) 1-methylguanosine-deficient tRNA of Salmonella enterica 
serovar Typhimurium affects thiamine metabolism. J. Bacteriol. 185, 750-759 
36. Tkaczuk, K. L., Dunin-Horkawicz, S., Purta, E., and Bujnicki, J. M. (2007) Structural and 
evolutionary bioinformatics of the SPOUT superfamily of methyltransferases. BMC 
Bioinformatics 8, 73 
37. Nureki, O., Watanabe, K., Fukai, S., Ishii, R., Endo, Y., Hori, H., and Yokoyama, S. (2004) Deep 
knot structure for construction of active site and cofactor binding site of tRNA modification 
enzyme. Structure 12, 593-602 
 	 16 
38. Leulliot, N., Bohnsack, M. T., Graille, M., Tollervey, D., and Van Tilbeurgh, H. (2008) The yeast 
ribosome synthesis factor Emg1 is a novel member of the superfamily of alpha/beta knot fold 
methyltransferases. Nucleic Acids Res. 36, 629-639 
39. Taylor, A. B., Meyer, B., Leal, B. Z., Kotter, P., Schirf, V., Demeler, B., Hart, P. J., Entian, K. D., 
and Wohnert, J. (2008) The crystal structure of Nep1 reveals an extended SPOUT-class 
methyltransferase fold and a pre-organized SAM-binding site. Nucleic Acids Res. 36, 1542-1554 
40. White, T. A., and Kell, D. B. (2004) Comparative genomic assessment of novel broad-spectrum 
targets for antibacterial drugs. Comp. Funct. Genomics 5, 304-327 
41. Hill, P. J., Abibi, A., Albert, R., Andrews, B., Gagnon, M. M., Gao, N., Grebe, T., Hajec, L. I., 
Huang, J., Livchak, S., Lahiri, S. D., McKinney, D. C., Thresher, J., Wang, H., Olivier, N., and 
Buurman, E. T. (2013) Selective inhibitors of bacterial t-RNA-(N(1)G37) methyltransferase 
(TrmD) that demonstrate novel ordering of the lid domain. J. Med. Chem. 56, 7278-7288 
42. Lahoud, G., Goto-Ito, S., Yoshida, K., Ito, T., Yokoyama, S., and Hou, Y. M. (2011) 
Differentiating analogous tRNA methyltransferases by fragments of the methyl donor. RNA 17, 
1236-1246 
43. Fuchs, S., Pane-Farre, J., Kohler, C., Hecker, M., and Engelmann, S. (2007) Anaerobic gene 
expression in Staphylococcus aureus. J. Bacteriol. 189, 4275-4289 
44. Campeotto, I., Zhang, Y., Mladenov, M. G., Freemont, P. S., and Gründling, A. (2015) Complex 
Structure and Biochemical Characterization of the Staphylococcus aureus Cyclic Diadenylate 
Monophosphate (c-di-AMP)-binding Protein PstA, the Founding Member of a New Signal 
Transduction Protein Family. J. Biol. Chem. 290, 2888-2901 
45. Gonzalez-Pinzon, R., Haggerty, R., and Myrold, D. D. (2012) Measuring aerobic respiration in 
stream ecosystems using the resazurin-resorufin system. J. Geophys. Res. Biogeosci. 117 
46. Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R., McWilliam, H., 
Remmert, M., Soding, J., Thompson, J. D., and Higgins, D. G. (2011) Fast, scalable generation of 
high-quality protein multiple sequence alignments using Clustal Omega. Mol. Sys. Biol. 7, 539 
47. Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., and Sternberg, M. J. E. (2015) The Phyre2 
web portal for protein modeling, prediction and analysis. Nat. Protoc. 10, 845-858 
48. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. 
(1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. 
Nucleic Acids Res. 25, 3389-3402 
49. Katoh, K., and Standley, D. M. (2013) MAFFT multiple sequence alignment software version 7: 
improvements in performance and usability. Mol. Biol. Evol. 30, 772-780 
50. Criscuolo, A., and Gribaldo, S. (2010) BMGE (Block Mapping and Gathering with Entropy): a 
new software for selection of phylogenetic informative regions from multiple sequence 
alignments. BMC Evol. Biol. 10, 210 
51. Ronquist, F., Teslenko, M., van der Mark, P., Ayres, D. L., Darling, A., Hohna, S., Larget, B., Liu, 
L., Suchard, M. A., and Huelsenbeck, J. P. (2012) MrBayes 3.2: efficient Bayesian phylogenetic 
inference and model choice across a large model space. Syst. Biol. 61, 539-542 
52. Shih, A. C., Lee, D. T., Peng, C. L., and Wu, Y. W. (2007) Phylo-mLogo: an interactive and 
hierarchical multiple-logo visualization tool for alignment of many sequences. BMC 
Bioinformatics 8, 63 
53. Karimova, G., Dautin, N., and Ladant, D. (2005) Interaction network among Escherichia coli 
membrane proteins involved in cell division as revealed by bacterial two-hybrid analysis. J. 
Bacteriol. 187, 2233-2243 
54. Guzman, L. M., Belin, D., Carson, M. J., and Beckwith, J. (1995) Tight regulation, modulation, 
and high-level expression by vectors containing the arabinose pBAD promoter. J. Bacteriol. 177, 
4121-4130 
55. Fey, P. D., Endres, J. L., Yajjala, V. K., Widhelm, T. J., Boissy, R. J., Bose, J. L., and Bayles, K. 
W. (2013) A Genetic Resource for Rapid and Comprehensive Phenotype Screening of 
Nonessential Staphylococcus aureus Genes. Mbio 4, e00537-12 
 	 17 
 
Table 1: Bacterial strains used in this study 
Strain Relevant features Reference 
 Escherichia coli strains  
XL1 Blue Cloning strain, TetR – ANG127 Stratagene 
BL21(DE3) E. coli strain used for protein expression – 
ANG191 
Novagen 
DHM1 cyaA mutant E. coli strain - ANG1310 (53) 
ANG1824 XL1 Blue pET28b; KanR Novagen 
ANG1867 BL21(DE3) pET28b; KanR Novagen 
ANG3168 BL21(DE3) pET28b-His6-CyaAEC(2-446); KanR This study 
ANG3412 DH5α pBAD33; CamR (54) 
ANG3413 XL1 Blue pBAD33-cyaAEC(2-446)-His6; CamR This study 
ANG3414 XL1 Blue pBAD33-SAUSA300_0905-His6; 
CamR 
This study 
ANG3434 DHM1 pBAD33-cyaAEC(2-446)-His6; CamR This study 
ANG3435 DHM1 pBAD33-SAUSA300_0905-His6 ; CamR This study 
ANG3436 DHM1 pBAD33; CamR This study 
ANG3290 T7IQ pVL791-His6-SACOL1008; CamR;CarbR This study 
ANG3650 BL21(DE3) pET28b-His6-TrmDEC; KanR This study 
ANG3651 BL21(DE3) pET28b-His6-TrmDSA; KanR This study 
ANG3682 XL1 Blue pET28b-His6-TrmDEC-Y86F; KanR This study 
ANG3683 XL1 Blue pET28b-His6-TrmDEC-Y86L; KanR This study 
ANG3684 XL1 Blue pET28b-His6-TrmDSA-LMC-YLS; 
KanR 
This study 
ANG3685 XL1 Blue pET23b-His6-TrmDTB; KanR This study 
ANG3686 BL21(DE3) pET28b-His6-TrmDEC-Y86F; KanR This study 
ANG3687 BL21(DE3) pET28b-His6-TrmDEC-Y86L; KanR This study 
ANG3688 BL21(DE3) pET28b-His6-TrmDSA-LMC-YLS; 
KanR 
This study 
ANG3689 BL21(DE3) pET23b-His6-TrmDTB; KanR This study 
ANG3895 T7IQ pVL791-His6-SACOL2653; CamR;CarbR This study 
ANG3999 XL1 Blue pET28b-His6-CyaAEC(2-446); KanR This study 
ANG4001 XL1 Blue pET28b-His6-TrmDEC; KanR This study 
ANG4002 XL1-Blue  pET28b-His6-TrmDSA; KanR This study 
   
 S. aureus strains  
JE2 USA300 MRSA strain (ANG2624) (55) 
NE1299  JE2 SAUSA300_0905::Tn; ErmR (ANG3894) (55) 
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Table 2: Primers used in this study 
 
Number Name Sequence 
ANG1918 5-NheI-MG1655 TrmD  CTAGGCTAGCTGGATTGGCATAATTAGCCTGTTT
CCTGAAATG 










ANG2152 EcTrmDY86F-R TGACAGAAAAATCACCTTTGCGCCTTC 
ANG2153 EcTrmDY86F-F GTGATTTTTCTGTCACCACAGGGACGCAAG 
ANG2154 EcTrmDY86L-R TGACAGTAAAATCACCTTTGCGCCTTC 
ANG2155 EcTrmDY86L-F GTGATTTTACTGTCACCACAGGGACGCAAG 
ANG2156 SaTrmDLMC-YLS-R GGAGAGGTAAATAACGCGTGTTTGTTC 
ANG2157 SaTrmDLMC-YLS-F GTTATTTACCTCTCCCCACAAGGCGAGCCATTTT
C 
ANG2158 Rv2906c Forward GCCATATGGCACACCACCACCACCACCACATGC
GCATCGATATCGTGAC 
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FIGURE LEGENDS  
Figure 1. TrmD from S. aureus binds 3’,5’-cAMP with high affinity. A, Binding curve and Kd 
determination between 3’,5’-cAMP and TrmDSA. Radiolabeled 3’,5’-cAMP and purified His-TrmDSA 
protein ranging from 1.5 nM to 200 µM were used in DRaCALAs, the average fraction bound values and 
standard deviation of four replicates plotted, and the curve fitted and Kd value determined as previously 
described (17). Representative DRaCALA spots are shown on top of the graph. B, Nucleotide binding 
competition assays. 100 µM of purified His-TrmDSA protein was incubated with radiolabeled 3’,5’-cAMP 
(ca. 2 nM) and 0.4 mM of the indicated cold competitor nucleotide or 0.4 mM or 1 mM AdoMet and 2’3’-
cAMP. The average fraction bound values and standard deviations from four spots were determined and 
plotted. C, The S. aureus CRP-like transcription factor ArcR does not bind 3’,5’-cAMP. Radiolabeled 
3’,5’-cAMP was incubated as negative control (NC) in the absence of protein, or purified TrmDSA or 
ArcR proteins (from two different purifications) at a concentration of 150 or 50 µM, as indicated. Average 
fraction bound values and standard deviation from four experiments are plotted. D, Chemical structures of 
3’,5’-cAMP and S-adenosinemethionine (AdoMet). 
 
 
Figure 2. 2’,3’-cAMP, but not 3’,5’-cAMP, is present in S. aureus. Semi-quantitative measurements of 
2’,3’-cAMP in extracts prepared from wild-type S. aureus strain JE2 and the isogeneic SAUSA300_0905 
mutant strain (∆0905). A, Bacteria were grown in TSB medium with/without agitation or B, in B-medium 
supplemented with 25 mM of glucose or sucrose. As indicated in the graph, extracts were either prepared 
from logarithmic (log) phase cultures or stationary (stat) phase cultures. 
 
 
Figure 3. SAUSA300_0905 is likely not a genuine adenylate cyclase. A, In vitro adenylate cyclase 
activity assay. Radiolabeled ATP was incubated as negative control (NC) in the absence of protein, as 
positive control with purified E. coli CyaA(2-446) protein (CyaAEC) or with purified histidine-tagged 
SAUSA300_0905 protein (0905). The reactions were set up in three different buffer systems as specified 
in the experimental procedures section and incubated at 37oC for 1h. Aliquots were separated by thin 
layer chromatography (TLC) and radiolabeled compounds visualized using a phosphoimager. A 
representative result of three experiments is shown. B, In vivo adenylate cyclase activity. The empty 
vector pBAD33 (EV), and plasmids pBAD-cyaAEC(2-446)-His6 (CyaAEC) or pBAD-SAUSA300_0905-
His6 (0905) were introduced into the cyaA mutant E. coli strain DHM1. The transformants were spotted 
onto LB plate supplemented with 50 µg/ml X-gal and 0.02% arabinose. C, Detection of CyaAEC-His6 and 
SAUSA300_0905-His6 by western blot. E. coli DHM1 containing plasmid pBAD33, pBAD-cyaAEC-His6 
or pBAD-SAUSA300_0905-His6 was propagated in LB medium without or with 0.02% arabinose. Whole 
cell lysates were prepared as described in the experimental procedures section, proteins separated on a 
12% SDS-PAGE gel and His-tagged proteins detected using a His-tag specific antibody. 
 
Figure 4. SAUSA300_0905 is distinct from genuine type IV adenylate cyclase. A, Partial sequence 
alignment and Logo motifs based on amino acid identity for Y. pestis CyaB and S. aureus 
SAUSA300_0905 homologs. Homologs of CyaB and SAUSA300_0905 were identified by a BLASTP 
search and multiple sequence alignments performed within and across the two groups as outlined in the 
experimental procedures section. Key sections of the sequence logo motifs for CyaB homologs (and 
likely genuine adenylate cyclases; AC) and SAUSA300_0905 homologs (hypothetical adenylate cyclases; 
hAC) are shown above or below the alignment, respectively. The sequences of a few representative 
proteins are shown, which include 3N10, the CyaB adenylate cyclase class IV from Y. pestis; ACah, 
WP_048207795.1, adenylate cyclase from Aeromonas hydrophila; ACvf, WP_044367144.1, adenylate 
cyclase from Vibrio fluvialis; ACpp, CAG22648.1, putative adenylate cyclase CyaB from Photobacterium 
profundum SS9; hACsa, SAUSA300_0905 from S. aureus; hACbs, KJJ42798.1, hypothetical protein 
UM89_04625 from Bacillus subtilis; hAClm, CCO63569.1, uncharacterized protein YjbK from Listeria 
monocytogenes LL195; hACsp, CIQ15488.1, adenylate cyclase from Streptococcus pneumoniae; hACll, 
 	 20 
WP_010905301.1, adenylate cyclase from Lactococcus lactis. Grey stars indicate residues conserved in 
both groups of proteins; green stars indicate residues specific for homologs of genuine adenylate cyclases 
and orange stars amino acids conserved in SAUSA300_0905 and its homologs. B, Structural model of the 
S. aureus protein SAUSA300_0905. Left panel: structure of the adenylate cyclase enzyme CyaB from Y. 
pestis (PDB code 3N0Y) with key amino acid residues involved in ligand binding shown in a stick 
representation. Right panel: structural model of the S. aureus protein SAUSA300_0905 predicted with 
Phyre2 and modelled on bh2851, a putative adenylate cyclase from Bacillus halodurans (PDB code 
2GFG). 94% of residues modelled at >90% confidence. Grey sticks indicate residues conserved in both 
groups of proteins; green and yellow sticks indicate highly conserved residues specific for CyaB and 
SAUSA300_0905 homologs, respectively. 
 
Figure 5. The TrmD proteins from E. coli and M. tuberculosis do not bind 3’,5’-cAMP. A, Coomassie 
stained SDS-PAGE gel. About 7.5 µg of the indicated WT or mutant TrmD protein variants were 
separated on a 12 % SDS-PAGE gel and proteins visualized by Coomassie staining. B, Binding curve and 
Kd determination between 3’,5’-cAMP and the E. coli, M. tuberculosis and S. aureus TrmD proteins. 
Radiolabeled 3’,5’-cAMP and purified TrmDSA, TrmDEC and TrmDMT protein ranging from 1.5 nM to 200 
µM were used in DRaCALAs, the average fraction bound values and standard deviation of four values 
were plotted, and the curve fitted and Kd value determined as previously described (17). 
 
Figure 6. Comparison of AdoMet-binding site residues found in TrmD proteins from Firmicutes, γ-
proteobacteria and Actinobacteria. A, Sequence logos motifs of AdoMet-binding site residues found in 
TrmD proteins from Firmicutes, γ-proteobacteria and Actinobacteria. TrmD proteins from bacteria 
belonging to the Firmicutes, γ-proteobacteria and Actinobacteria were retrieved, sequence alignments and 
logo motifs prepared and displayed in the Clustal X default colour scheme as described in the 
experimental procedures section. Amino acid residues forming the AdoMet-binding site were identified 
and labeled as Motifs A (further split into A1 and A2), B and C. Motifs A2, B and C and are highly 
conserved between the three groups while motif A1 is variable. Amino acid numbers indicated above the 
logo motif section is based on the S. aureus COL strain TrmD protein. B, ConSurf model of AdoMet-
binding site motifs of TrmD proteins. A multi-sequence alignment was generated for TrmD proteins found 
in Firmicutes, γ-Proteobacteria and Actinobacteria and mapped using the ConSurf server onto the 
structure of the AdoMet-bound H. influenza TrmD protein (PDB code 1UAK). Purple represents high, 
white medium and green low conservation. The AdoMet ligand is shown as stick model and areas with 
motif A1, A2, B and C amino acids are circled. 
 
 
Figure 7. Tyr86 in E. coli TrmD is critical to discriminate between 3’,5’-cAMP and AdoMet. A, 
Comparison of the AdoMet-binding pockets of the S. aurues and H. influenza TrmD proteins. The apo-
structures of the S. aureus TrmD (PDB code 3KY7; shown in yellow) was overlaid in PyMOL with the 
AdoMet-bound structure of the H. influenza TrmD (PDB 1UAK, show in grey). A zoomed in view of the 
ligand binding pocket is shown in cartoon representation, with the AdoMet, Tyr86 of TrmDEC and Leu84 
of TrmDSA shown as stick model. Tyr86 of TrmDEC forms two hydrogen bonds with 2’- and 3’-OH of the 
ribose ring of AdoMet, while Leu84 of TrmDSA probably cannot. B-C, Binding curve and Kd 
determination between 3’,5’-cAMP and (B) WT S. aureus TrmD and indicated variant and (C) WT E. coli 
TrmD protein and indicated variants. Radiolabeled cAMP and purified TrmDSA, or the TrmDSA-LMC-
YLS variant, TrmDEC or the TrmDEC-Y86F and TrmDEC-Y86L variants ranging from 1.5 nM to 200 µM 
were used in DRaCALAs, the average fraction bound values and standard deviation of at least three 
values were plotted, and the curve fitted and Kd value determined as previously described (17). D, Logo 
motifs of the TrmD protein A motif amino acids of representative Firmicutes. The TrmD protein 
sequences from 78 representative Firmicutes, as described in Galperin et al. (11), were retrieved and 
grouped into sequences from bacteria likely lacking a bona fide adenylate cyclase [no AC (n=69)] or 
containing an adenylate cyclase [with AC (n=9)]. The sequences were aligned separately and logo motifs 
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generated and displayed in the Clustal X default colour scheme. The TrmD A motif was split as described 
in Fig. 6A into motifs A1 and A2 motifs and amino acid number indicated above each logo motif section 
is based on the S. aureus strain COL TrmD protein sequence. 
Figure 8. Cartoon representation of the hydrogen-bonding networks between S-adenosylmethionine or its 
analogs and bacterial tRNA/rRNA methyltransferases. The substrate binding pockets are shown for A, 
tRNA MTases TrmD (tRNA (guanine-N(1)-)-methyltransferase, in complex with AdoMet, PDB code 
1UAK), B, TrmH (tRNA (guanosine(18)-2'-O)-methyltransferase, in complex with AdoMet, PDB code 
1V2X), C, MjNep1 (ribosomal RNA small subunit methyltransferase, in complex with sinefungin, PDB 
code 3BBH), D, TrmL (tRNA (cytidine(34)-2'-O)-methyltransferase in complex with AdoHcy, PDB code 
1MXI), E, rRNA MTases ScNep1 (ribosomal RNA small subunit methyltransferase Nep1, in complex 
with AdoMet, PDB code 2V3K), F, RsmE (ribosomal RNA small subunit methyltransferase E, in 
complex with AdoMet, PDB code 2Z0Y). AdoMet, AdoHcy and sinefungin and key protein amino acid 
residues involved in hydrogen bond (yellow dotted lines) formation with the 2’ and 3’-OH in the substrate 
are shown in stick models (carbon, white; oxygen, red; nitrogen, blue; sulphur, orange). Small grey dots 
indicate water molecules. Images were generated in Pymol. 
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